PharmExec Direct:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile
PharmExec Direct | From the editors of Pharmaceutical Executive Visit the PharmExec website
Send Us Some Feedback
 
January 13, 2011 | ISSUE NUMBER 182 VOL 8

R&D
Pain and Promise: Tufts' R&D Outlook for 2011
Industry faces a cumulative tide of challenges marked by a dramatic reversal in societal attitudes toward risk, according to the Tufts Center for Drug Development’s annual assessment of the state of R&D in Big Pharma.

Strategy
Sanofi's Fresh Bet on Patient-Centric R&D
With a new R&D structure and a high-profile appointment to lead it, Sanofi is banking on a new industry model to replenish its anemic pipeline of new products.

Outlook
New Decade, New Agenda
A new track for nonprofits, product diversification, and the rise of the emerging markets—just some of the takeaways from this week’s JP Morgan Healthcare Conference.

Social Media
Physicians Online: Know Your Network
Online physician communities are like candy stores for brand managers. Or are they?


// Sanofi-aventis US (Bridgewater, NJ) announced the addition of Robert Cuddihy, M.D. Vice President, Medical Diabetes, to its recently established Diabetes Divisions. //Rick Finnegan became Executive Vice President of International Business in the Commercial Services division of inVentiv Health (Somerset, NJ). // Trius Therapeutics (San Diego) appointed J. Craig Thompson to the newly created role of Chief Commercial Officer. //Burson-Marsteller (San Francisco) announced the appointment of Melissa Grigorieff Koomey as Managing Director and head of the company’s West Coast Healthcare Practice. //

Jan 24–25, 2011: 8th Annual Pharmaceutical Compliance Congress
Washington, DC


Jan 26–28: Drug Delivery Partnerships
Miami, FL

Feb 1–2, 2011: Pharma Market Research
Parsippany, NJ

 

 
FindPharma  
Search  

Survey
Who do you think will become the most influential healthcare stakeholders in the next few years?
Click To Vote
 
 
Quick Links

Will 2011 be the Year of Innovation?

FDA Deputy Commissioner Sharfstein to Leave Agency

GSK Responds to “60 Minutes” Segment on Manufacturing Issues


Follow Pharm Exec on Twitter
Follow Pharm Exec on Facebook

User Management
| Subscribe | Update My Profile | Send Feedback | Advertise With Us | Visit PharmExec.com |

You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To ensure delivery to your Inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.

Visit Pharmaceutical Executive